Dr Tom Barnes
Tom Barnes has led gene discovery groups and biotherapeutic research teams for over 20 years and is responsible for the overall research and development strategy at Intellia. A veteran entrepreneur who has helped launch several companies, he has turned creative scientific visions into successful businesses for both startups and established organizations. Tom has wide-ranging knowledge of biological systems through his work across diverse platforms, including genomics, small molecule drug repositioning, and protein engineering. Prior positions include Vice President of Discovery at Eleven Biotherapeutics, Senior Vice President and site head of GeneLogic (Cambridge), and Director, Genomic Pharmacology at Millennium. Tom received his Ph.D. from Cambridge University, and completed research fellowships at Harvard Medical School and McGill University.